Bioage Labs Inc (BIOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||
| Net Income | -80,605 | -71,109 | -63,854 |
| Depreciation Amortization | 213 | 167 | 162 |
| Accounts receivable | -769 | N/A | N/A |
| Accounts payable and accrued liabilities | 788 | 6 | -393 |
| Other Working Capital | -11,828 | 11,176 | 6,710 |
| Other Operating Activity | 10,574 | 8,238 | 20,013 |
| Operating Cash Flow | $-81,627 | $-51,522 | $-37,362 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 60,250 | N/A | N/A |
| PPE Investments | -155,466 | -366 | -166 |
| Purchase Of Investment | N/A | N/A | -100 |
| Investing Cash Flow | $-95,216 | $-366 | $-266 |
| Cash Flows From Financing Activities | |||
| Debt Issued | -6,000 | -6,000 | 35,000 |
| Common Stock Issued | 714 | 212,395 | 4 |
| Other Financing Activity | 16,755 | 174,804 | -63 |
| Financing Cash Flow | $11,469 | $381,199 | $34,941 |
| Exchange Rate Effect | -87 | 81 | N/A |
| Beginning Cash Position | 354,349 | 24,957 | 27,644 |
| End Cash Position | 188,888 | 354,349 | 24,957 |
| Net Cash Flow | $-165,461 | $329,392 | $-2,687 |
| Free Cash Flow | |||
| Operating Cash Flow | -81,627 | -51,522 | -37,362 |
| Capital Expenditure | -155,466 | -366 | -166 |
| Free Cash Flow | -237,093 | -51,888 | -37,528 |